Kolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis Review

Date: December 31, 2013
Pages: 32
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: K59B2C41365EN
Leaflet:

Download PDF Leaflet

Kolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis Review
Kolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Kolon Life Science, Inc. (Kolon) is a life sciences company. The company manufactures and commercializes pharmaceutical ingredients and chemicals. Its products include loxoprofen sodium, sumatriptan succinate, donepezil hydrochloride, levofloxacin, felbinac, argatroban, ketoprofen, KP-324, CleanBio-NA, flocculants, flame retardants, electronic materials, antibacterial agents, high refraction monomer, therapeutic protein drug and cell-mediated gene therapy. Kolon’s technology platform produces and utilizes protein for human body by performing gene manipulation and cell culturing technology.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Section 1 - About the Company
Kolon Life Science, Inc. - Key Facts
Kolon Life Science, Inc. - Key Employees
Kolon Life Science, Inc. - Major Products and Services
Kolon Life Science, Inc. - Pharmaceutical Pipeline Products Data
Kolon Life Science, Inc., Pipeline Products by Therapy Area
Kolon Life Science, Inc., Pipeline Products by Development Phase
Kolon Life Science, Inc. - History
Kolon Life Science, Inc. - Company Statement
Kolon Life Science, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Kolon Life Science, Inc. - Business Description
Kolon Life Science, Inc. - SWOT Analysis
SWOT Analysis - Overview
Kolon Life Science, Inc. - Strengths
Strength - Diversified Business Portfolio
Strength - Research Expertise
Strength - Operational Efficiency
Kolon Life Science, Inc. - Weaknesses
Weakness - Declining Returns
Kolon Life Science, Inc. - Opportunities
Opportunity - Strategic Alliances
Opportunity - Pipeline Product Portfolio
Opportunity - Conducive Business Environment
Kolon Life Science, Inc. - Threats
Threat - Uncertain R&D Outcomes
Threat - Increased Drug Scrutiny
Threat - Government Regulations
Kolon Life Science, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kolon Life Science, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Kolon Life Science, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Kolon Life Science, Inc., Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Kolon Life Science, Inc., Key Facts
Kolon Life Science, Inc., Key Employees
Kolon Life Science, Inc., Major Products and Services
Kolon Life Science, Inc., Number of Pipeline Products by Therapy Area
Kolon Life Science, Inc., Number of Pipeline Products by Development Stage
Kolon Life Science, Inc., Pipeline Products By Therapy Area and Development Phase
Kolon Life Science, Inc., History
Kolon Life Science, Inc., Other Locations
Kolon Life Science, Inc., Key Competitors
Kolon Life Science, Inc., Ratios based on current share price
Kolon Life Science, Inc., Annual Ratios
Kolon Life Science, Inc., Interim Ratios
Kolon Life Science, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Kolon Life Science, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Kolon Life Science, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Kolon Life Science, Inc., Pipeline Products by Therapy Area
Kolon Life Science, Inc., Pipeline Products by Development Phase
Kolon Life Science, Inc., Performance Chart (2008 - 2012)
Kolon Life Science, Inc., Ratio Charts
Kolon Life Science, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Kolon Life Science, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Ask Your Question

Kolon Life Science, Inc. (102940) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: